Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.4.2.8 (
hypoxanthine-guanine phosphoribosyltransferase
)
2,527
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have examined whether cells with replication error-positive (RER+) and -negative phenotype (
RER
) respond differently to the mutagen MNNG, employing three RER+ and two
RER
- human cell lines. Cells were treated with several concentrations of MNNG, and
HPRT
mutants were selected phenotypically by their growth in the presence of 6-thioguanine. While the variation of the mutation frequency within each group was about an order of magnitude, it was found that MNNG induced a level of mutations in the
HPRT
gene some 100- to 1000-fold higher in RER+ cells than in cells with
RER
-phenotype. MNNG, at a concentration of 30 microM, produced a mutation frequency 450-fold higher in HCT116 (RER+) cells than in SW480 (
RER
-) cells. Our findings suggest that the RER+ phenotype predisposes cells to MNNG-induced hypermutability.
...
PMID:Frequency of HPRT gene mutations induced by N-methyl-N'-nitro-N-nitrosoguanidine corresponds to replication error phenotypes of cell lines. 962 69